J&J obtains FDA clearance for wider use of Prezista

The FDA approved Johnson & Johnson's HIV drug Prezista for use with Abbott Laboratories' Norvir in newly diagnosed patients. Prezista, a protease inhibitor, already had approval for use in patients who developed resistance to other therapies.

View Full Article in:

Wall Street Journal (tiered subscription model), The · Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA